Dan Yarosh
Dr. Yarosh received his BA degree in Biology from Macalester College, St. Paul, Minnesota, in 1976, and his Doctorate in Molecular Biology from the University of Arizona College Of Medicine in 1978. He served as a National Science Foundation Fellow at Brookhaven National Laboratory, Upton, New York, and then a Staff Fellow and Cancer Expert at the National Cancer Institute of the National Institutes of Health, Bethesda, Maryland. In 1985, Dr. Yarosh founded the biotechnology company AGI Dermatics, with an emphasis on the commercial application of DNA repair. He is the inventor of DimericineÒ (T4N5 liposome lotion), which is a liposomal DNA repair enzyme for the prevention of skin cancer. AGI Dermatics also supplied ingredients to many major worldwide cosmetic and personal care companies. In 2006 the company launched its own Remergent® brand of skincare products, including sunscreens and prescription drugs. In 2008, AGI Dermatics was acquired by Estee Lauder Co. Dr. Yarosh is a leader in the study of behavioral biology in beauty and skincare, merging neuroscience with marketing to understand consumer behavior.
Dr. Yarosh is the author of more than 140 scientific papers and two dozen patents. He has been an active participant in the dermatology and New York biotechnology communities, and is a speaker at skincare and dermatology meetings around the world. In 2004, the International Union of Photobiology presented Dr. Yarosh with the Finsen Award, which is granted every four years at the International Congress for Photobiology for breakthrough research in the photobiology sciences. He was honored by the American Cancer Society for his professional service in 2008. His book The New Science of Perfect Skin, about skincare technology in the cosmetic marketplace, was published by Random House in May 2008. He also published an historical novel, The Death of Hercules, in 2021.
Engagement Tasks:
Board of Directors and Scientific Advisory Board
Due Diligence and Patent Review and Analysis
Claims Support and Study Design
Strategic Commercialization of Breakthrough Technology
Expert Testimony in Litigation and Arbitration
Daniel B. Yarosh, PhD, is an independent advisor in cosmetics, beauty, dermatology, pharmaceuticals, biotechnology and neuromarketing. He founded and was President of AGI Dermatics, biotech company focused on commercial applications of DNA repair. His company developed new technologies for skin repair in dermatology and cosmetics, and cancer treatment for 23 years before it was acquired by Estee Lauder Co. He then served as Senior Vice President, Basic Science Research, and Chief Technology Advisor at Estee Lauder, and was responsible for the company’s worldwide basic research. Dr. Yarosh also served on the Board of Directors of Aceto Corp., a specialty chemical and generic drug company. He serves on the Scientific Advisory Board of several biotech companies focused on beauty and personal care.